Feud Intensifies Between ‘Hypocritical’ Planned

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
108
Feud Intensifies Between ‘Hypocritical’
Planned Parenthood and Ousted Physician President
< >

Dr.-Leana-Wen-640x480.png


The public feud between Planned Parenthood and its recently ousted physician president is intensifying as Dr. Leana Wen accuses the left-wing organization of hypocrisy and attempted intimidation.

In a letter to Planned Parenthood’s board of directors that was obtained by the New York Times, the former president and CEO accused the group of holding her health insurance and severance pay as “ransom” until she agreed to sign a confidentiality agreement.

In the letter, Wen reportedly wrote, “I have no desire to file claims against Planned Parenthood for defamation, retaliation, or discrimination,” but then added that the organization was demanding she stop speaking publicly “in exchange for my contractually-guaranteed severance and continued health insurance coverage.”

Wen referred to Planned Parenthood’s actions as “unjust” and “unethical,” said the Times.

The battle between Wen and the abortion giant comes as Planned Parenthood has been more open that abortion is its central priority.

Though, for years, the group insisted abortion was a very small part of the “healthcare” services it provided, ultimately Planned Parenthood opted not to remain in the federal Title X family planning grant program when the Trump administration decided to enforce the program’s rule that grantees of the funds not refer for or perform abortions.

The organization abandoned the program, leaving about $60 million behind in federal funding that will now be redirected to federally qualified healthcare centers that do not perform abortions.

In her letter, Wen reportedly referred to the Trump administration’s Title X rule enforcement as she accused Planned Parenthood’s board of hypocrisy.

“It is deeply hypocritical,” she wrote, that her former organization, “would attempt to enforce a gag order on its immediate past President/CEO while fighting the Trump administration’s gag rule on Title X providers.”

According to the Times, Melanie Newman, senior vice president for communications at Planned Parenthood, said Wen’s accusations are “unfortunate, saddening, and simply untrue.”

“The attorneys representing the board have made every good faith effort to amicably part from Dr. Wen, and are disappointed that they have been unable to reach a suitable resolution regarding her exit package,” she added.

Newman claims Wen received in her severance package a full additional year of salary and health benefits “under terms that are standard and consistent with her employment agreement and any reasonable executive exit package.”

Nevertheless, Wen, who expressed disappointment in a Twitter post that her letter leaked out, said, “There should be no dispute regarding the terms of my employment contract, which are clearly spelled out.”

The ousted president’s tenure at Planned Parenthood lasted less than a year. At the time Wen was hired, the organization announced her as its choice for president with much fanfare that Planned Parenthood would have its first physician president in decades. The group gave the appearance of showing interest in developing its non-abortion services.

When she was suddenly fired in July, Wen at first referred in a tweet to the reason for her ouster as “philosophical differences” with the board, but then elaborated on that reference in a three-page letter to Planned Parenthood colleagues and supporters.

She explained:

One year ago, when I came in front of the Search Committee selecting Planned Parenthood’s next President, I posed this question: Did they see Planned Parenthood as an advocacy organization first, with medical services that are necessary to strengthen its impact, or did they see Planned Parenthood as a health care organization first, with advocacy as a necessary vehicle to protect rights and access?

Wen said she believed she was coming in as Planned Parenthood president to “run a national health care organization and to advocate for the broad range of public health policies that affect our patients’ health.”

“The new Board leadership has determined that the priority of Planned Parenthood moving forward is to double down on abortion rights advocacy,” she said.

According to the Times, Wen said in her letter she believed the best way to protect Planned Parenthood from the Trump administration and states eager to restrict abortion and cut the group’s funding would be to de-emphasize its abortion services.

“However,” she reportedly wrote, “there is a vocal minority,” including many national staff and board members, “who prefer a stridently political, abortion-first philosophy.”

The struggle between Wen and the Planned Parenthood organization became palpable in January after Wen’s interview with BuzzFeed News that was published with the headline, “Planned Parenthood’s New President Wants to Focus on Nonabortion Health Care.”

Following its publication, however, Wen tweeted the headline “completely misconstrue[d] my vision for Planned Parenthood.”

The physician then made what may be the most memorable announcement of her tenure at Planned Parenthood: Abortion is “our core mission.”

After Wen’s ouster, a report at Politico indicated a former Planned Parenthood employee denied the existence of “philosophical differences” between Wen and the board. The anonymous ex-staff member described Wen as an “incompetent manager” who had done significant “damage” to the organization.

At the time of Wen’s ouster, Troy Newman, president of pro-life group Operation Rescue, said the developing feud between Wen and Planned Parenthood was providing the country with “a glimpse of the disarray and division within Planned Parenthood’s ranks.”

“What we are seeing right now is a desperate attempt to regain political power it lost when President Trump took office in 2017,” he added. “They are willing to throw anyone and everyone under the bus to get that power back.”

Currently, Planned Parenthood still receives over $500 million in taxpayer funds as reimbursements through the Medicaid program.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
TCL’s AI Vision: Immersive Living at IFA 2026

Updated Category News Views 1

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 3

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 0

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCryst Pharmaceuticals Celebrates ORLADEYO's Landmark Approval

Updated Category News Views 152

BioCryst Pharmaceuticals Achieves Significant Reimbursement Milestone BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has made a significant stride in the healthcare market by securing reimbursement for ORLADEYO (berotralstat) across major European nations. This breakthrough follows a positive recommendation from the Zorginstituut Nederland, leading to ORLADEYO's approval...

Continue Reading
Zoom Communications Achieves Award for Broadcast Innovation Success

Updated Category News Views 296

Zoom Communications Triumphs with Emmy Award Recognition In an impressive showcase of innovation, Zoom Communications, Inc. (NASDAQ: ZM) has received the prestigious Engineering, Science & Technology Emmy® Award. This accolade honors the company's revolutionary Zoom for Broadcast technology, which plays a significant role in enhancing broadcast capabilities across...

Continue Reading
Israel Acquisitions Corp. Reaches New Heights in Stock Prices

Updated Category News Views 46

Israel Acquisitions Corp. Achieves Significant Stock Milestone In a remarkable turn of events, shares of Israel Acquisitions Corp. (ISRL) have soared to a 52-week high, trading at an impressive $11.21. This achievement signifies a crucial milestone in the company's journey, showcasing its robust performance over the past year. The rising confidence among investors is...

Continue Reading
Oculis Advances Transformative Eye Drop Therapy for DME

Updated Category News Views 138

Oculis’ Innovative Approach to Treat Diabetic Macular Edema Oculis Holding AG (Nasdaq: OCS), a pioneering biopharmaceutical company dedicated to enhancing eye health, has made significant strides in treating diabetic macular edema (DME) through its revolutionary OCS-01 eye drops. These high-concentration dexamethasone eye drops are formulated with Oculis' unique...

Continue Reading
Pony AI Inc. Secures Permit for Driverless Robotaxi Services

Updated Category News Views 208

Pony AI Inc. Achieves Major Milestone in Autonomous Mobility Pony AI Inc. has made headlines recently by receiving a permit to operate fully driverless commercial robotaxi services in various urban districts. This remarkable announcement came during a significant event focused on artificial intelligence, signaling an important transition in the way transportation services...

Continue Reading